Drug interactions
Lonapegsomatropin + Metformin-sitagliptin
Severity: Moderate
Lonapegsomatropin and Metformin-sitagliptin: moderate interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Lonapegsomatropin is a long-acting growth hormone that can reduce insulin sensitivity, especially at higher doses. In patients with diabetes this may raise glucose and reduce the effect of metformin and sitagliptin.
What this interaction means in plain words
Lonapegsomatropin and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken.
Lonapegsomatropin belongs to Endocrine; Metformin-sitagliptin belongs to Endocrine.
Why it happens
Growth hormone induces insulin resistance and increases hepatic glucose output, opposing antidiabetic effects.
What to do
Monitor blood glucose closely when starting or adjusting lonapegsomatropin. Increase antidiabetic therapy if hyperglycemia develops.
What to ask your pharmacist
- Should I take them at different times of day?
- Does the dose of either medicine need to change?
- Is there anything I should avoid, such as alcohol or certain foods, while on both?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Lonapegsomatropin and Metformin-sitagliptin, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Metformin-sitagliptin
Other interactions of Lonapegsomatropin
Frequently asked questions
Can I take Lonapegsomatropin with Metformin-sitagliptin?
MediHelp rates the interaction as moderate. Lonapegsomatropin and Metformin-sitagliptin can affect each other. The combination is often manageable, but it may need a change of dose, a change of timing, or extra checks while both are taken. Lonapegsomatropin is a long-acting growth hormone that can reduce insulin sensitivity, especially at higher doses. In patients with diabetes this may raise glucose and reduce the effect of metformin and sitagliptin.
How serious is the interaction between Lonapegsomatropin and Metformin-sitagliptin?
MediHelp rates it moderate, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor blood glucose closely when starting or adjusting lonapegsomatropin. Increase antidiabetic therapy if hyperglycemia develops.
What other medicines interact with Metformin-sitagliptin?
MediHelp also lists interactions of Metformin-sitagliptin with, for example, Clozapine, Contrast media, Diatrizoate meglumine / diatrizoate. The full list is on the Metformin-sitagliptin page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
